Skip to Content

IN150 > (Ibandronate Sodium 150 mg (base))

Pill with imprint IN150 > is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc..

Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for IN150 >

Ibandronate Sodium

Imprint:
IN150 >
Strength:
150 mg (base)
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3770

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide